550 related articles for article (PubMed ID: 25269391)
21. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
22. Interventions for the prevention of recurrent erysipelas and cellulitis.
Dalal A; Eskin-Schwartz M; Mimouni D; Ray S; Days W; Hodak E; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009758. PubMed ID: 28631307
[TBL] [Abstract][Full Text] [Related]
23. [Pneumocystis pneumonia in patients with immunosuppression other than HIV infection].
Adler D; Chenivesse C; Similowski T; Soccal PM
Rev Med Suisse; 2008 Nov; 4(180):2525-6, 2528-30. PubMed ID: 19127897
[TBL] [Abstract][Full Text] [Related]
24. Long-term antibiotics for preventing recurrent urinary tract infection in children.
Williams G; Craig JC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroids for pneumonia.
Stern A; Skalsky K; Avni T; Carrara E; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007720. PubMed ID: 29236286
[TBL] [Abstract][Full Text] [Related]
26. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Goldenberg JZ; Yap C; Lytvyn L; Lo CK; Beardsley J; Mertz D; Johnston BC
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006095. PubMed ID: 29257353
[TBL] [Abstract][Full Text] [Related]
27. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
[TBL] [Abstract][Full Text] [Related]
29. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
30. Interventions for primary vesicoureteric reflux.
Williams G; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD001532. PubMed ID: 30784039
[TBL] [Abstract][Full Text] [Related]
31. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
32. Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial.
Abe Y; Fujibayashi K; Nishizaki Y; Yanagisawa N; Nojiri S; Nakano S; Tada K; Yamaji K; Tamura N
Acta Med Okayama; 2019 Feb; 73(1):85-89. PubMed ID: 30820060
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic therapy for pelvic inflammatory disease.
Savaris RF; Fuhrich DG; Duarte RV; Franik S; Ross J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010285. PubMed ID: 28436019
[TBL] [Abstract][Full Text] [Related]
34. Isoniazid for preventing tuberculosis in HIV-infected children.
Zunza M; Gray DM; Young T; Cotton M; Zar HJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006418. PubMed ID: 28850172
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: A systematic review and meta-analysis.
Li R; Tang Z; Liu F; Yang M
PLoS One; 2021; 16(3):e0248524. PubMed ID: 33765022
[TBL] [Abstract][Full Text] [Related]
36. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy.
Chokephaibulkit K; Wanachiwanawin D; Chearskul S; Wanprapa N; Unganont K; Tantinikorn W; Udompunthurak S
Pediatr Infect Dis J; 1999 Feb; 18(2):147-52. PubMed ID: 10048687
[TBL] [Abstract][Full Text] [Related]
37. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
38. Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.
Katsuyama T; Saito K; Kubo S; Nawata M; Tanaka Y
Arthritis Res Ther; 2014 Feb; 16(1):R43. PubMed ID: 24495443
[TBL] [Abstract][Full Text] [Related]
39. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.
Siu JT; Nguyen T; Turgeon RD
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012123. PubMed ID: 33294991
[TBL] [Abstract][Full Text] [Related]
40. Risk factors associated with increased discontinuation rate of trimethoprim-sulfamethoxazole used as a primary prophylaxis for Pneumocystis pneumonia: A retrospective cohort study.
Otani T; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Hirata S; Fujitaka K; Hamada H; Sugiyama E; Hattori N
Pulm Pharmacol Ther; 2021 Apr; 67():101999. PubMed ID: 33571651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]